The National Chemotherapy Board and Cancer Research UK are pleased to launch the Guidance on the consent for SACT and national SACT regimen-specific consent forms. The aim of the guidance and forms is to support clinicians to ensure that patients receiving SACT are fully informed when consenting to treatment.
The guidance document encompasses:
- Background to consent for SACT
- National Chemotherapy Board recommendations and the national regimen-specific consent forms
- Guidance for the introduction of the national regimen-specific consent forms by individual chemotherapy providers, e.g. gaining approval from your Trust governance/consent committees
- Guidance for the process of consent for SACT
- Recommendations for the audit of consent procedures
Documentation can be accessed and downloaded from the Cancer Research UK website: www.cruk.org/sact_consent.
Author(s)
